Search results - 75 results

Validation of a rapid SARS-CoV-2 antibody test in general practice

Stefan; Van den Bruel, Ann; I Desombere; Van Damme, Pierre; Goossens, Herman; Buret, Laetitia; Duysburgh, Els; Coenen, Samuel Source: BMJ Open, Volume 13, Issue 5 (2023) Health Topics:  Health and disease ...

Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults

Verbrugghe, Mathieu; Van Loon, Nele; Dierick, Katelijne; Matagne, André; I Desombere; Ariën, Kevin K.; Marchant, Arnaud; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Health Topics:  Health and ...

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial

I Desombere; Kevin K. Ariën; Maria Goossens Source: PLOS Global Public Health, Volume 2, Issue 12 (2022) Keywords: COVID-19; fractional dose; reduced dose; mRNA vaccination; non-inferiority; SARS-CoV-2 Abstract: ...

Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.

Lisa Verheggen; Debbie Le Blon; Bart Peeters; Maria Goossens; Pieter Pannus; Ariën, Kevin K; Sébastien Anguille; Annelies Janssens; Hans Prenen; Evelien L J Smits; Christof Vulsteke; Eva Lion; Peeters, ...

Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.

Den Bruel; I Desombere; Van Damme, Pierre; Goossens, Herman; Laëtitia Buret; Els Duysburgh; Coenen, Samuel Source: BMJ Open, Volume 12, Issue 9 (2022) Keywords: Adult Belgium COVID-19 Female Follow-Up ...

Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.

I Desombere; Sébastien Anguille; Zwi Berneman; Maria Goossens; Goossens, Herman; Surbhi Malhotra-Kumar; Evelina Tacconelli; Timon Vandamme; Peeters, Marc; Peter van Dam; Samir Kumar-Singh Source: Front Immunol, ...

Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.

Evelyne Willems; Grégory Ehx; Stanislas Goriely; Laurence Seidel; Johan Michiels; Betty Willems; Maria Goossens; Yves Beguin; Arnaud Marchant; Frédéric Baron Source: Cancer Cell, Volume 40, Issue 4 (2022) ...

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.

A Martens; Van Esbroeck, Marjan; Maria Goossens; Arnaud Marchant; Koen Bartholomeeusen; I Desombere Source: NPJ Vaccines, Volume 7, Issue 1 (2022) Abstract: We report the levels of neutralising antibodies ...

Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients.

Publication Type: Peer reviewed scientific article Authors: Delphine Kemlin; Anne Lemy; Pieter Pannus; I Desombere; Nicolas Gemander; Maria Goossens; Arnaud Marchant; Le Moine, Alain Source: Am ...

QR code

QR code for this page URL